Health Canada
- Status: approved
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (INSULIN SUSP ISOPHANE RECOMBINANT HUMAN) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Marketing authorisation holder not available in our data.